MedTrace Logo

VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway

NCT01917370 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-08-06

No results posted yet for this study

Summary

The investigators study the VEGF signaling in ICC cell lines／human tissues and its mechanism in HCC growth, proliferation and apoptosis.

Conditions

  • Intrahepatic Cholangiocarcinoma

Interventions

PROCEDURE

surgical treatment

all the patients in the study must have been treated by the surgery at the first time and have been confirmed as 'complete section' by the post-surgery radiological image.

Sponsors & Collaborators

  • Guangdong Province, Department of Science and Technology

    collaborator OTHER_GOV

  • First Affiliated Hospital, Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Ming Kuang, MD · First Affiliated Hospital, Sun Yat-Sen University

Eligibility

Min Age
16 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-12-31
Completion
2014-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917370 on ClinicalTrials.gov